|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.73 USD | +2.33% |
|
-4.29% | +9.93% |
Phibro Animal Health Corporation reaffirmed earnings guidance for the fiscal year 2024. The company affirms previously issued fiscal year 2024 guidance for the following measures: Net sales of $980 million to $1.020 billion, growth of 2%, affirmed. Net income of $12 million to $17 million, a decline of 55%, updated.
Diluted EPS of $0.30 to $0.42, a decline of 56%, updated.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.93% | 516M | |
| -19.73% | 72.39B | |
| -11.01% | 6.54B | |
| +15.88% | 3.43B | |
| -0.68% | 1.4B | |
| -17.27% | 1.34B | |
| -2.73% | 1.26B | |
| -28.16% | 1.2B | |
| -14.67% | 1.12B | |
| -5.37% | 990M |
PHIBRO ANIMAL HEALTH CORPORATION 
